Counterfeit Parts and Suspect Components
Risk of unauthorized, fraudulent, or substandard components entering the supply chain.
Definition
Counterfeit electronic components and substandard materials have caused field failures and recalls in MedTech. Mitigation includes authorized-distributor sourcing, incoming inspection, and AS6081/AS6171-style detection methods for electronics. Risk is highest during component shortages, when buyers turn to brokers. Controls include requiring certificates of conformance, testing samples for authenticity, and quarantining suspect parts. SAE AS5553 covers counterfeit avoidance for electronic parts. Suspect parts found after use should be assessed through CAPA and, where needed, field action decisions.What this means in practice
Heightened concern after EUA-era ventilator and respirator supply chains exposed widespread component fraud.Examples
- A medical device manufacturer implements a new supplier qualification process requiring all component suppliers to provide certificates of authenticity and traceability documentation for critical components.
- During incoming inspection, a MedTech company uses X-ray fluorescence (XRF) spectroscopy to verify the material composition of received components against specifications, identifying a batch of resistors made with incorrect alloys.
- Following a field failure report, an investigation reveals that a crucial integrated circuit in an implanted device was a remarked, substandard component obtained from an unauthorized broker, leading to a product recall.
- •A common pitfall is relying solely on price as a purchasing criterion, which can inadvertently lead to the acquisition of counterfeit or substandard components.
- •Another mistake is neglecting to conduct regular audits of suppliers and their quality systems, missing early indicators of potential supply chain vulnerabilities.
- •Failing to implement a robust incoming inspection process risks integrating non-conforming components directly into medical devices, jeopardizing patient safety and device effectiveness.
- •Misinterpreting “authorized distributor” as a blanket guarantee of authenticity without verifying the distributor’s specific authorization for the purchased components is a common misconception.
- •Overlooking the need for specialized training for personnel involved in component procurement and inspection can lead to inadequate identification of suspect parts.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Manufacturing
· Same categoryStructured list of every component, sub-assembly, and quantity needed to manufacture a device.
Quantification of viable microorganisms on or in a product before sterilization.
ISO 14644 classification of cleanrooms by airborne particulate cleanliness (ISO 1 through ISO 9).
Demonstration that a sterile package maintains microbial barrier and contents integrity over the labeled shelf life.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1SAE AS6081Tier 2 VerifiedSAEsae.org
- 2FDA - Device ManufacturingTier 2 VerifiedFDAfda.gov
- 3ISO 13485 Standard PageTier 1 VerifiedISOiso.org
Inline markers like [1] jump to the matching reference above.